We are live on
!
Find out more
SP
Symmetry Partners Portfolio holdings
AUM
$1.96B
1-Year Est. Return
19.83%
This Fund
S&P 500
This Quarter
Est. Return
-3.27%
1 Year Est. Return
+19.83%
3 Year Est. Return
+58.53%
5 Year Est. Return
+62.51%
10 Year Est. Return
–
AUM
$1.59B
AUM Growth
+$18.4M
(+1.2%)
Cap. Flow
+$84.8M
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
33.4%
Holding
616
New
13
Increased
89
Reduced
73
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
|
+$63.1M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$11.6M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$7.38M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$6.74M |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$6.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$21.3M |
| 2 |
abrdn Physical Precious Metals Basket Shares ETF
GLTR
|
+$12.8M |
| 3 |
iShares MSCI Intl Momentum Factor ETF
IMTM
|
+$11.4M |
| 4 |
FM
iShares Frontier and Select EM ETF
FM
|
+$4.04M |
| 5 |
Pfizer
PFE
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.36% |
| 2 | Financials | 5.72% |
| 3 | Healthcare | 4.65% |
| 4 | Industrials | 4.08% |
| 5 | Consumer Discretionary | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
176
Garmin
GRMN
$58.2B
| $1.12M | 0.07% |
9,424
| – | – |
|
177
Cigna
CI
$72.7B
| $1.11M | 0.07% |
4,622
| – | – |
|
178
Teledyne Technologies
TDY
$31.9B
| $1.1M | 0.07% |
2,327
| – | – |
|
179
Citizens Financial Group
CFG
$30.5B
| $1.09M | 0.07% |
24,010
-27,444
| -53% | -$1.41M |
|
180
Bank of Montreal
BMO
$127B
| $1.09M | 0.07% |
9,238
| – | – |
|
181
Linde
LIN
$226B
| $1.08M | 0.07% |
3,389
| – | – |
|
182
McKesson
MCK
$102B
| $1.08M | 0.07% |
3,527
+480
| +16% | +$131K |
|
183
Pool Corp
POOL
$7.31B
| $1.07M | 0.07% |
2,527
| – | – |
|
184
SLB Ltd
SLB
$76.5B
| $1.06M | 0.07% |
25,684
| – | – |
|
185
Merck
MRK
$317B
| $1.05M | 0.07% |
12,856
+3,129
| +32% | +$247K |
|
186
CBRE Group
CBRE
$42.7B
| $1.04M | 0.07% |
11,416
| – | – |
|
187
Honeywell
HON
$76.3B
| $1.04M | 0.07% |
5,682
| – | – |
|
188
Toronto Dominion Bank
TD
$200B
| $1.04M | 0.07% |
13,119
+2,623
| +25% | +$211K |
|
189
Micron Technology
MU
$996B
| $1.04M | 0.07% |
13,351
| – | – |
|
190
Marathon Petroleum
MPC
$84B
| $1.04M | 0.07% |
12,125
| – | – |
|
191
Jefferies Financial Group
JEF
$13B
| $1.04M | 0.07% |
32,988
-22,593
| -41% | -$767K |
|
192
Norfolk Southern
NSC
$76.9B
| $1.04M | 0.07% |
3,631
| – | – |
|
193
Goldman Sachs
GS
$301B
| $1.03M | 0.07% |
3,131
-3,536
| -53% | -$1.25M |
|
194
RTX Corp
RTX
$301B
| $1.03M | 0.06% |
10,411
| – | – |
|
195
Lockheed Martin
LMT
$135B
| $1.02M | 0.06% |
2,302
+1,151
| +100% | +$467K |
|
196
Ally Financial
ALLY
$13.4B
| $1.01M | 0.06% |
23,292
| – | – |
|
197
Amgen
AMGN
$219B
| $994K | 0.06% |
4,110
| – | – |
|
198
Lennar Class A
LEN
$20.4B
| $991K | 0.06% |
12,615
-3,621
| -22% | -$326K |
|
199
O'Reilly Automotive
ORLY
$76.2B
| $988K | 0.06% |
21,645
| – | – |
|
200
CSX Corp
CSX
$93.9B
| $976K | 0.06% |
26,067
| – | – |
|
Similar funds
HA
NIM
TCM
FC
BC
FFH
RMCM
OCM
Symmetry Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Symmetry Partners held 616 positions worth $1.59B, up 1.2% from $1.57B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Symmetry Partners deployed $84.8M of net new capital in Q1 2022, opening 13 new positions and adding to 89 existing holdings. Its largest new stake was JPMorgan BetaBuilders US Aggregate Bond ETF: 1,213,000 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 9.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $3.51M trimmed.
- Symmetry Partners's largest Q1 2022 buy was JPMorgan BetaBuilders US Aggregate Bond ETF: 1,213,000 shares worth $61.3M.
- Symmetry Partners added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $11.6M increase.
- Symmetry Partners's biggest Q1 2022 reduction was Pfizer, cutting an estimated $3.51M.
- Symmetry Partners fully exited Vanguard Morningstar Mid-Cap Value ETF in Q1 2022, selling an estimated $21.3M.
- Symmetry Partners's ten largest holdings make up 33% of its $1.59B portfolio in Q1 2022.
- Symmetry Partners opened 13 new positions and closed 45 in Q1 2022.
- Symmetry Partners's portfolio value rose 1.2% quarter-over-quarter to $1.59B.
Based on Symmetry Partners's 13F filing for Q1 2022, filed 4 Apr 2022.